Invitae Corporation (NYSE:NVTA) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Invitae Corporation (NYSE:NVTA) gained 4.98 Percent and closed its previous trading session at $9.91. The stock traded with the average Volume of 907.25 Million at the end of last session.
Invitae Corporation (NYSE:NVTA) has the Market Capitalization of 700.64 Million. The Stock has its 52-week High of $10.41 and 52-Week Low of $ 4.35 and it touched its 52-week high on 08/24/17 and 52-Week Low on 03/28/18
The company reported its last earnings Actual EPS of $-0.47/share. While, the analyst predicted that the company could provide an EPS of $-0.54/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.07/share which shows an Earnings Surprise of 13 Percent.
Sell side analysts plays vital role in buying and selling a stock where 1 analysts rated Invitae Corporation (NYSE:NVTA) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 16.84% where SMA50 and SMA200 are 22.77% and 31.99% respectively.
The company shows its Return on Assets (ROA) value of -68.7%. The Return on Equity (ROE) value stands at -127.4%. While it’s Return on Investment (ROI) value is -42.5%.
Invitae Corporation (NYSE:NVTA) currently has a Weekly Volatility of 7.28% percent while its Monthly Volatility is at 5.39% percent. While talking about Performance of the Stock, Invitae Corporation currently has a Weekly performance of 20.12%, monthly performance percentage is 21.6 percent, Quarterly performance is 50.84 percent, 6 months performance shows a percent value of 60.62% and Yearly Performance is 7.48 percent.
Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.